2021
DOI: 10.1016/j.resuscitation.2021.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Continuous flow insufflation of oxygen for cardiac arrest: Systematic review of human and animal model studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…The impact of CFIO on patient-centred outcomes is still unclear. 5 , 7 , 11 To our knowledge, only two trials have compared the use of CFIO to other methods of ventilation in human studies. 5 , 7 These two randomized controlled trials included 95 and 696 patients and were conducted in France.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The impact of CFIO on patient-centred outcomes is still unclear. 5 , 7 , 11 To our knowledge, only two trials have compared the use of CFIO to other methods of ventilation in human studies. 5 , 7 These two randomized controlled trials included 95 and 696 patients and were conducted in France.…”
Section: Discussionmentioning
confidence: 99%
“…While the CFIO device maintains a positive alveolar pressure, ventilation is delivered by the concomitant chest compressions to achieve adequate gas exchanges. 5 7 The impact of CFIO on patients’ outcomes is unclear but CFIO was associated with improved gas exchange parameters 5 , 7 11 and increased coronary perfusion pressure 10 in small human cohort studies and animal model studies.…”
Section: Introductionmentioning
confidence: 99%
“…Boussignac tube, or with the combination of an oropharyngeal airway and standard mask with non-rebreather reservoir. Current evidence on this novel strategy derives from two randomized controlled trials (RCTs), enrolling 95 and 944 Out-of-Hospital Cardiac Arrest, respectively, in which the Boussignac tube was used for passive oxygen delivery [15][16][17]. No differences in any survival outcomes were observed [17].…”
Section: Novel Cardiopulmonary Resuscitation Strategiesmentioning
confidence: 99%